Sign Up Today and Learn More About Quanta Therapeutics Stock
Invest in or calculate the value of your shares in Quanta Therapeutics or other pre-IPO companies through EquityZen's platform.
Quanta Therapeutics Stock (QUTH)
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
About Quanta Therapeutics Stock
Founded
2018
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Quanta Therapeutics Press Mentions
Stay in the know about the latest news on Quanta Therapeutics
Quanta Therapeutics patents new KRAS mutant inhibitors for cancer
bioworld • Oct 11, 2024
Great progress from the Quanta team!
linkedin • Aug 05, 2024
Quanta Announces Dosing of First Patient in Phase 1/1b
globenewswire • Aug 05, 2024
Quanta Therapeutics’ Post
linkedin • Aug 05, 2024
Multi-KRAS Inhibitor Shows High Preclinical Selectivity and Potent Activity
genengnews • Jun 25, 2024
Quanta Therapeutics Management
Leadership team at Quanta Therapeutics
Chief Medical Officer
Leonardo Faoro
Chief Business Officer & co-founder
Cameron Pitt
Join now and verify your accreditation status to gain access to:
- Quanta Therapeutics current valuation
- Quanta Therapeutics stock price
- Available deals in Quanta Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Quanta Therapeutics Stock
How to invest in Quanta Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Quanta Therapeutics through EquityZen funds. These investments are made available by existing Quanta Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Quanta Therapeutics stock?
Shareholders can sell their Quanta Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
